Stocks making the biggest moves premarket: UnitedHealth, TSMC, GE Aerospace, J.B. Hunt & more
Premarket movers included UnitedHealth, TSMC, GE Aerospace, United Airlines, J.B. Hunt, AtaiBeckley, AeroVironment, and Rocket Companies. UnitedHealth rose after Q2 results and an increased full-year outlook. TSMC fell after raising capex guidance and adding $100B in Arizona. AtaiBeckley jumped on Eli Lilly’s $2.8B buy offer. Other stocks moved on earnings, guidance, or analyst upgrades/targets.
How this was made

The 30-second read
Why it matters
The article provides concrete, time-sensitive catalysts (earnings beats with raised outlook, capex guidance increases, deal premium, and guidance softness) that can drive immediate repricing at the open.
Market read
Traders can use the specific catalysts and the directionality implied by premarket moves to set watch levels and reassess near-term expectations for earnings, guidance, capex intensity, and deal certainty.
What to watch
For deal-driven ATB/LLY, traders may be underweighting closing risk and milestone probability; for TSM, capex timing and ROI assumptions could dominate the next earnings cycle.
Background
This is a multi-name premarket movers wrap, attributing each move to a specific catalyst such as earnings/guidance, capex changes, an M&A agreement, or an analyst upgrade/PT change.
Ticker impact
UnitedHealth shares rose more than 7% premarket after it posted better-than-expected Q2 results and hiked its full-year outlook.
Likely continued premarket strength and elevated volatility into the open as traders reprice full-year expectations.
The article cites a specific EPS and revenue beat versus LSEG estimates and explicitly states the company raised full-year earnings outlook.
TSMC fell about 4% premarket after raising full-year capex guidance to $60B to $64B and announcing an additional $100B Arizona investment.
Potential for further downside or choppy trading as investors weigh capex intensity against demand visibility.
The text confirms an earnings beat but the stock move is attributed to higher capex and the scale of the Arizona investment.
GE Aerospace shares dropped about 4% premarket even after beating Q2 EPS and revenue, because it raised full-year guidance.
Near-term pressure likely persists until traders clarify what the raised guidance implies for margins and demand.
The article states the stock fell despite a beat and that full-year guidance was raised, but it does not provide the guidance details or the market’s specific concern.
Eli Lilly was up fractionally premarket after agreeing to buy AtaiBeckley for $2.8B, with potential milestone payments.
Limited upside follow-through unless traders focus on pipeline value and milestone probability.
The article provides deal price and potential additional per-share payments, but does not quantify expected financial impact beyond the cash offer structure.
United Airlines shares fell more than 3% premarket after topping earnings estimates but issuing softer-than-expected Q3 guidance and expecting $6B added fuel costs.
Downward pressure likely at the open as traders adjust forward earnings expectations for Q3 and fuel headwinds.
The article cites Q3 EPS guidance below FactSet estimates and explicitly mentions $6B in added fuel costs.
J.B. Hunt shares jumped nearly 7% premarket after Q2 EPS beat by 18 cents and management said intermodal demand increased throughout the quarter.
Potential for continued strength into the open, with momentum traders watching for follow-through volume.
The article provides specific EPS and revenue figures versus estimates and includes a qualitative demand improvement statement.
AeroVironment rose nearly 2% premarket after Raymond James upgraded it to outperform from market perform, citing recovering bookings and growing backlog.
Mild-to-moderate upside follow-through possible if the market agrees with the backlog recovery narrative.
The article ties the move to a named upgrade and specific operational claims, but it is still an analyst-driven catalyst rather than a company disclosure.
Rocket Companies added about 2% premarket after Morgan Stanley raised its price target to $19 and reiterated a buy rating.
Likely modest upside bias at the open, with limited duration unless new company-specific catalysts emerge.
The article provides the new target and implied upside, but no new earnings or guidance from RKT itself.
Market effects
Health insurance and transport names show earnings-guidance sensitivity, while semicapex intensity and airline fuel-cost expectations reinforce sector-level margin focus.
US premarket tape likely drives near-term risk appetite across defensives (UNH) and cyclicals (UAL, GE, JBHT).
TSMC’s capex and Arizona investment signal ongoing global semiconductor capacity buildout, influencing broader semicapex expectations.
Counterpoint
Some stocks moved opposite the headline (GE down despite raised guidance and beats), suggesting the market may be reacting to guidance quality or margin assumptions not detailed here.
Key entities
- companyUnitedHealth
Q2 results beat and full-year earnings outlook raised, driving a >7% premarket move.
- companyTSMC
Raised full-year capex guidance and announced additional Arizona investment, driving a ~4% premarket decline.
- companyGE Aerospace
Despite Q2 beat and raised full-year guidance, shares fell ~4% premarket.
- companyAtaiBeckley
Jumped ~34.5% on an Eli Lilly acquisition agreement at $6.75 per share cash.
- companyEli Lilly
Fractionally higher on the AtaiBeckley deal, including potential additional milestone payments.




